The small but real possibility of this side effect has two positives. It means that my fear that they might just give Invokana indiscriminately to everyone who has high blood pressure, leaving no role for PromarkerD, is unfounded.
And for me at least it shows that CKD is a very serious business if people are potentially prepared to risk this for a cure. For me at least it follows that people should be very keen to be tested by PromarkerD in order to be able to take steps to prevent CKD if it might be likely to occur.
Austrade support for PromarkerD, page-30
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
88.0¢ |
Change
-0.020(2.22%) |
Mkt cap ! $115.1M | |||
| Open | High | Low | Value | Volume |
| 91.0¢ | 91.0¢ | 86.5¢ | $99.60K | 112.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8000 | 87.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 89.0¢ | 16900 | 1 |
View Market Depth
| Last trade - 15.54pm 28/06/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |